THE PREFERENTIAL DOPAMINE D-3 RECEPTOR-LIGAND, (+)-UH 232, IS A PARTIAL AGONIST

被引:28
|
作者
GRIFFON, N
PILON, C
SCHWARTZ, JC
SOKOLOFF, P
机构
[1] Unité de Neurobiologie et Pharmacologie de l'INSERM, Centre Paul Broca, 75014 Paris, 2ter, rue d'Alésia
关键词
MITOGENESIS; CAMP FORMATION; INTRINSIC ACTIVITY;
D O I
10.1016/0014-2999(95)00460-3
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In a NG 108 15 hybrid cell line stably expressing a recombinant dopamine D-3 receptor, (+)-UH 232 (cis-(+)-1S,2R)-5-methoxy-1-methyl-2-(di-n-propylamino)tet a partially selective D-3 receptor ligand, stimulates mitogenesis, as measured by incorporation of [H-3]thymidine, with an EC(50) of 7.6 nM and a maximal increase corresponding to 23% of the response elicited by quinpirole, a full agonist. This effect was antagonised by nafadotride, a D-3 receptor-selective antagonist. (+)-UH 232 also antagonised quinpirole-induced mitogenesis with a Xi value of 9.4 nM. (+)-UH 232(1 mu M) inhibited by 22% the forskolin-induced accumulation of cAMP, whilst the inhibition by quinpirole (100 nM) was 53%. These results indicate that (+)-UH 232 is a partial agonist at the D-3 receptor with an intrinsic activity of 0.2-0.4.
引用
收藏
页码:R3 / R4
页数:2
相关论文
共 50 条
  • [1] Antipsychotics with inverse agonist activity at the dopamine D-3 receptor
    Griffon, N
    Pilon, C
    Sautel, F
    Schwartz, JC
    Sokoloff, P
    JOURNAL OF NEURAL TRANSMISSION, 1996, 103 (10) : 1163 - 1175
  • [2] (+)-UH232 AND (+)-UH242 - NOVEL STEREOSELECTIVE DOPAMINE RECEPTOR ANTAGONISTS WITH PREFERENTIAL ACTION ON AUTORECEPTORS
    SVENSSON, K
    HJORTH, S
    CLARK, D
    CARLSSON, A
    WIKSTROM, H
    ANDERSSON, B
    SANCHEZ, D
    JOHANSSON, AM
    ARVIDSSON, LE
    HACKSELL, U
    NILSSON, JLG
    JOURNAL OF NEURAL TRANSMISSION, 1986, 65 (01) : 1 - 27
  • [3] PHARMACOLOGICAL ASPECTS OF R-(+)-7-OH-DPAT, A PUTATIVE DOPAMINE D-3 RECEPTOR-LIGAND
    DAMSMA, G
    BOTTEMA, T
    WESTERINK, BHC
    TEPPER, PG
    DIJKSTRA, D
    PUGSLEY, TA
    MACKENZIE, RG
    HEFFNER, TG
    WIKSTROM, H
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 249 (03) : R9 - R10
  • [4] EFFECTS OF THE DOPAMINE D-3 RECEPTOR-LIGAND 7-OH-DPAT ON MALE-RAT EJACULATORY BEHAVIOR
    AHLENIUS, S
    LARSSON, K
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1995, 51 (2-3) : 545 - 547
  • [5] The locomotor effects of a putative dopamine D-3 receptor agonist in developing rats
    Frantz, K
    Babcock, D
    VanHartesveldt, C
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 302 (1-3) : 1 - 6
  • [6] Dopamine D-3 receptor antagonists
    Lloyd, AW
    DRUG DISCOVERY TODAY, 1996, 1 (06) : 261 - 261
  • [7] Nafadotride, a potent preferential dopamine D-3 receptor antagonist, activates locomotion in rodents
    Sautel, F
    Griffon, N
    Sokoloff, P
    Schwartz, JC
    Launay, C
    Simon, P
    Costentin, J
    Schoenfelder, A
    Garrido, F
    Mann, A
    Wermuth, CG
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1995, 275 (03): : 1239 - 1246
  • [8] In vivo evidence for preferential role of dopamine D-3 receptor in the presynaptic regulation of dopamine release but not synthesis
    Gainetdinov, RR
    Sotnikova, TD
    Grekhova, TV
    Rayevsky, KS
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 308 (03) : 261 - 269
  • [9] D-3 Dopamine Receptor and Essential Hypertension
    Zeng, Chunyu
    Eisner, Gilbert M.
    Felder, Robin A.
    Jose, Pedro A.
    CURRENT HYPERTENSION REVIEWS, 2006, 2 (03) : 247 - 253
  • [10] Inhibition of dopamine neuron firing by pramipexole, a dopamine D-3 receptor-preferring agonist, comparison to other dopamine receptor agonists
    Piercey, MF
    Hoffmann, WE
    Smith, MW
    Hyslop, DK
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 312 (01) : 35 - 44